Andrew Barry Singleton

Title: Andrew Barry Singleton: Innovator in Neurodegenerative Disease Diagnosis

Introduction

Andrew Barry Singleton is a prominent inventor based in Poolesville, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in neurodegenerative diseases and acute ischemic stroke. With a total of two patents to his name, Singleton's work is paving the way for advancements in healthcare.

Latest Patents

Singleton's latest patents include a method for diagnosing a neurodegenerative disease. This invention relates to assessing whether a subject has or is likely to develop a neurodegenerative disease by determining if the subject has a mutation in the C9orf72 gene. This mutation disrupts C9orf72 expression compared to subjects without the mutation. Another notable patent is focused on biomarkers for acute ischemic stroke. This invention provides methods and compositions for diagnosing acute ischemic stroke and distinguishing it from other forms of stroke and transient ischemic attacks (TIAs). Additionally, it offers methods to facilitate the treatment of patients suffering from acute ischemic stroke.

Career Highlights

Throughout his career, Singleton has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Pittsburgh. His experience in these institutions has greatly influenced his research and innovations.

Collaborations

Some of Singleton's notable coworkers include Taura L Barr and Maria Del Mar Matarin. Their collaborative efforts have contributed to the advancements in the field of medical diagnostics.

Conclusion

Andrew Barry Singleton's innovative work in diagnosing neurodegenerative diseases and acute ischemic stroke showcases his commitment to improving healthcare. His patents reflect a deep understanding of complex medical conditions and a dedication to finding effective solutions.